10 Years Of MedImmune: What Trademark Owners Learned

Law360, New York (February 14, 2017, 11:09 AM EST) -- Last month marked 10 years since the U.S. Supreme Court sided with MedImmune in a royalty dispute with Genentech, transferring the power within a license agreement from the licensor to the licensee. This Law360 Expert Analysis series explores the decision's impact on licensing and litigation.

James E. Griffith

Michelle Bolos Ten years ago, the Supreme Court redefined the standards for declaratory judgment jurisdiction in patent cases, forcing practitioners to reimagine intellectual property enforcement strategies. In MedImmune LLC v. Genentech Inc., the Supreme Court held that a...
To view the full article, register now.